Clinical Trials
3 trialsNCT02267707 2019-11-01
Pharmacokinetic and Safety Study of NabĀ®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
Celgene
Phase 1 Terminated
NCT02104076 2017-07-05
EvolutionĀ® Biliary Stent System-Fully Covered
Cook Group Incorporated
Phase NA Completed
NCT00080236 2012-08-10
Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation
Conatus Pharmaceuticals Inc.
Phase 2 Completed